Fatty acid synthase (FASN), an enzyme that drives de novo lipogenesis, plays a relevant role in metabolic disorders such as obesity, non-alcoholic fatty liver disease (NAFLD) or type 2 diabetes.

They lower serum LDL-C levels by competitively inhibiting the enzyme HMG-CoA reductase ... factor 1 (SREBP-1), PPAR-γ coactivator-1α (PGC-1α), sirtuin 1 (SIRT1), fatty acid synthase (FASN), ...

While the body naturally produces nitric oxide, certain foods can enhance its production, leading to improved overall ...

Depending on the desaturase enzyme used, the position and number of double bonds ... These intermediates enter fatty acid synthase (FAS), where four reactions take place; condensation, reduction, ...

This study aims to (i) generate draft genomes from Lake Stechlin; (ii) to screen these genomes for new complete multi-modular enzymes from PKS and NRPS ... Type II, and Fabs, Fatty acid synthase). The ...

The novel variety was developed from the NorLin flax variety by insertion of a sulfonylurea tolerant mutant of the acetolactate synthase (ALS) gene. The ALS gene encodes an enzyme involved ...

Consuming one gram of omega-3 per day may slow down the rate of biological aging in humans, according to an analysis of data ...

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

which is an essential fatty acid as it cannot be synthesized de novo in animals. The primary precursor is obtained from the diet in the form of linoleic acid. The two COX enzymes have different ...

Fatty Liver Symptoms: If you notice a combination of these symptoms, consult a healthcare provider Fatty liver, or hepatic steatosis, is a condition where excess fat builds up in liver cells. It ...